Clinical and Microbiological Characteristics of Heteroresistant and Vancomycin-Intermediate Staphylococcus Aureus From Bloodstream Infections in a Brazilian Teaching Hospital

PLoS ONE - United States
doi 10.1371/journal.pone.0160506
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Molecular Analysis and Frequency of Staphylococcus Aureus Virulence Genes Isolated From Bloodstream Infections in a Teaching Hospital in Tianjin, China

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2013English

Comparison of E Test GRD and Vancomycin Screen Agar (BHI-V3 and BHI-V4) in Detection of Heteroresistant Vancomycin Intermediate Staphylococcus Aureus (hVISA).

The Professional Medical Journal
2019English

Molecular Epidemiology of a Vancomycin-Intermediate Heteroresistant Staphylococcus Epidermidis Outbreak in a Neonatal Intensive Care Unit

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2016English

Molecular and Phenotypic Characteristics of Methicillin-Resistant and Vancomycin-Intermediate Staphylococcus Aureus Isolates From Patients With Septic Arthritis

Journal of Clinical Microbiology
Microbiology
2009English

Heterogeneous Vancomycin-Intermediate Among Methicillin Resistant Staphylococcus Aureus

Medical Journal Armed Forces India
Medicine
2015English

Selection of Heterogeneous Vancomycin-Intermediate Staphylococcus Aureus by Imipenem

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2009English

Predictors of Clinical and Microbiological Treatment Failure in Neonatal Bloodstream Infections

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2015English

Association of Vancomycin MIC and Molecular Characteristics With Clinical Outcomes in Methicillin-Susceptible Staphylococcus Aureus Acute Hematogenous Osteoarticular Infections in Children

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Emergence of Dalbavancin Non-Susceptible, Vancomycin-Intermediate Staphylococcus Aureus (VISA) After Treatment of MRSA Central Line-Associated Bloodstream Infection With a Dalbavancin- And Vancomycin-Containing Regimen

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy